We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

71 hedge funds and large institutions have $61.3M invested in ChemoCentryx, Inc. in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 13

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

9% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 11

1% less funds holding

Funds holding: 7271 (-1)

70% less capital invested

Capital invested by funds: $203M → $61.3M (-$142M)

90% less call options, than puts

Call options by funds: $15K | Put options by funds: $155K

Holders
71
Holders Change
-1
Holders Change %
-1.39%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
10
Increased
29
Reduced
13
Closed
11
Calls
$15K
Puts
$155K
Net Calls
-$140K
Net Calls Change
+$182K
Name Holding Trade Value Shares
Change
Change in
Stake
BI
1
BVF Inc
California
$20.4M +$5.48M +1,504,330 +23%
WA
2
Wasatch Advisors
Utah
$5.73M +$63.7K +17,481 +0.7%
Franklin Resources
3
Franklin Resources
California
$5.39M +$1.45M +396,900 +22%
Capital World Investors
4
Capital World Investors
California
$3.71M -$7.2M -1,977,392 -57%
BFA
5
BlackRock Fund Advisors
California
$3.19M +$92.4K +25,382 +2%
Vanguard Group
6
Vanguard Group
Pennsylvania
$2.54M +$229K +63,009 +7%
Balyasny Asset Management
7
Balyasny Asset Management
Illinois
$2.38M -$2.46M -676,192 -41%
AG
8
Artal Group
Luxembourg
$2.24M
VC
9
Vivo Capital
California
$2.21M +$3.23M +887,906 New
CS
10
Credit Suisse
Switzerland
$1.91M +$988K +271,384 +55%
GCM
11
Gruss Capital Management
New York
$1.2M
BIT
12
BlackRock Institutional Trust
California
$1.1M +$574K +157,707 +56%
State Street
13
State Street
Massachusetts
$1.03M +$7.33K +2,014 +0.5%
Northern Trust
14
Northern Trust
Illinois
$743K -$4.5K -1,235 -0.4%
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$592K +$185K +50,893 +27%
A
16
Abingworth
United Kingdom
$533K
PI
17
Putnam Investments
Massachusetts
$500K
Renaissance Technologies
18
Renaissance Technologies
New York
$421K +$454K +124,754 +282%
Jacobs Levy Equity Management
19
Jacobs Levy Equity Management
New Jersey
$362K +$529K +145,313 New
SIM
20
Spark Investment Management
New York
$308K +$451K +123,900 New
BA
21
BlackRock Advisors
Delaware
$292K +$101K +27,655 +31%
BIM
22
BlackRock Investment Management
Delaware
$249K +$6.62K +1,818 +2%
TCIM
23
TIAA CREF Investment Management
New York
$248K
Bank of America
24
Bank of America
North Carolina
$246K +$215K +59,137 +148%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$236K +$54.2K +14,895 +19%

CCXI Hedge Fund Activity: Q1 2016 in Review

71 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q1 2016, worth a combined $61.3M — down 70% from $203M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of CCXI and 10 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 29 added.

The largest buyer was BVF Inc, adding an estimated $5.48M. The largest seller was Westfield Capital Management, exiting entirely with an estimated $8.93M sold.

  • 71 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q1 2016, down from 72 in Q4 2015.
  • Funds reported $61.3M of ChemoCentryx, Inc. stock for Q1 2016, down 70% quarter-over-quarter.
  • 10 funds opened new ChemoCentryx, Inc. positions in Q1 2016 and 11 closed out, a net change of -1 holder.
  • The largest ChemoCentryx, Inc. buyer in Q1 2016 was BVF Inc, an estimated $5.48M added.
  • The largest ChemoCentryx, Inc. seller in Q1 2016 was Westfield Capital Management, an estimated $8.93M sold.

Based on aggregated 13F filings for Q1 2016.